Atrion (NASDAQ:ATRI) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Atrion (NASDAQ:ATRI) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the medical instruments supplier’s stock.

Atrion Price Performance

Shares of Atrion stock opened at $459.92 on Tuesday. The firm has a market cap of $809.46 million, a price-to-earnings ratio of 43.23 and a beta of 0.69. The stock has a 50-day simple moving average of $457.78 and a 200-day simple moving average of $438.27. Atrion has a 52-week low of $274.98 and a 52-week high of $503.24.

Atrion (NASDAQ:ATRI) last posted its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 EPS for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%. The company had revenue of $48.77 million during the quarter.

Institutional Trading of Atrion

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Quadrant Capital Group LLC bought a new position in shares of Atrion in the 4th quarter valued at approximately $36,000. Headlands Technologies LLC bought a new position in shares of Atrion in the second quarter valued at approximately $54,000. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of Atrion in the second quarter worth $72,000. EntryPoint Capital LLC bought a new stake in shares of Atrion during the 1st quarter worth $91,000. Finally, Comerica Bank boosted its holdings in shares of Atrion by 60.9% during the 1st quarter. Comerica Bank now owns 415 shares of the medical instruments supplier’s stock worth $192,000 after buying an additional 157 shares during the period. Institutional investors and hedge funds own 66.19% of the company’s stock.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.